Predicting outcome in melanoma: where are we now?
Jennings, L Murphy, G M
Jennings, L
Murphy, G M
Citations
Altmetric:
Author
Advisors
Editors
Other Contributors
Date
2009-09
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adult
Early Detection of Cancer
Female
Humans
Lymphangiogenesis
Male
Melanoma
Middle Aged
Neoplasm Staging
Prognosis
Sentinel Lymph Node Biopsy
Skin Neoplasms
Tomography, Emission-Computed
Tumor Markers, Biological
Young Adult
Early Detection of Cancer
Female
Humans
Lymphangiogenesis
Male
Melanoma
Middle Aged
Neoplasm Staging
Prognosis
Sentinel Lymph Node Biopsy
Skin Neoplasms
Tomography, Emission-Computed
Tumor Markers, Biological
Young Adult
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
Melanoma incidence continues to rise in most countries. This is of grave concern, given the mortality rate in a relatively young population. Current staging tools are limited in their ability to predict accurately those at risk of metastatic disease, relapse and treatment failure. This overview comprehensively reviews relevant literature, with the focus on the last 5 years, and discusses the current state of traditional and emerging novel methods of staging for melanoma and their effect on prognosis in this population.
Language
en
ISSN
1365-2133
eISSN
ISBN
DOI
10.1111/j.1365-2133.2009.09324.x
PMID
19624540